Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.

Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study. Radiology. 2010 May; 255(2):622-8.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Brain Neoplasms
Contrast Media
Disease Progression
Drug Administration Schedule
Female
Glioblastoma
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Angiography
Male
Middle Aged
Neovascularization, Pathologic
Pilot Projects
Predictive Value of Tests
Proportional Hazards Models
Retrospective Studies

authors with profiles

Timothy Carroll